日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: A Bayesian Analysis

COVID-19 大流行对美国结核病治疗结果的影响:贝叶斯分析

Swartwood, Nicole A; Cohen, Ted; Marks, Suzanne M; Hill, Andrew N; Beeler Asay, Garrett R; Self, Julie; Feng, Pei-Jean I; Horsburgh, C Robert; Salomon, Joshua A; Menzies, Nicolas A

In-kind Nutritional Supplementation for Persons With Drug-susceptible Tuberculosis and Their Household Contacts Would be Cost-effective for Reducing Tuberculosis Incidence and Mortality in Jharkhand, India: A Modeling Study

在印度贾坎德邦,为药物敏感性结核病患者及其家庭密切接触者提供实物营养补充,对于降低结核病发病率和死亡率具有成本效益:一项建模研究

Sinha, Pranay; Bhargava, Madhavi; Dauphinais, Madolyn R; Carwile, Madeline E; Horsburgh, C Robert Jr; Singh, Urvashi B; Sarkar, Sonali; Bhargava, Anurag; Menzies, Nicolas A

Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks

针对艾滋病毒感染者的长效结核病治疗方案:成本效益基准

Zheng, Amy; Pletner, Eden; Middelkoop, Keren; Neilan, Anne M; Horsburgh, C Robert; Paltiel, A David; Freedberg, Kenneth A; Wood, Robin; Reddy, Krishna P

Adapting Back-calculation Methods to Estimate the Incidence of Tuberculosis

运用反算方法估算结核病发病率

Shapiro, Anne N; Mohammed, Shariq; Horsburgh, C Robert; Jenkins, Helen E; White, Laura F

TB-Free Chuuk: community-wide tuberculosis prevention and treatment with an integrated disease screening approach in Chuuk Lagoon, Federated States of Micronesia

无结核病楚克:在密克罗尼西亚联邦楚克泻湖地区采用综合疾病筛查方法开展社区结核病预防和治疗

Kern-Allely, Stephanie; Fred, Dorina; Dungawin, Mayleen; Balathandan, Thanumalaya Perumal; Defang, Rupihner R; Yadav, Subhash; Maharaj, Praneel; Horsburgh, C Robert; Carter, E Jane; Brostrom, Richard

Risk of rifampicin resistance emergence after incomplete first-line tuberculosis treatment

一线结核病治疗不彻底后出现利福平耐药性的风险

Dupuis, Genevieve N; Dolynska, Mariia; Chiang, Silvia S; Horsburgh, C Robert Jr; Stagg, Helen R; Rybak, Natasha R; Petrenko, Vasyl; Jenkins, Helen E

Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial

高剂量左氧氟沙星治疗耐多药结核病的疗效和安全性:一项随机、安慰剂对照的II期临床试验

Phillips, Patrick P J; Peloquin, Charles A; Sterling, Timothy R; Kaur, Pawandeep; Diacon, Andreas H; Gotuzzo, Eduardo; Benator, Debra; Warren, Robin M; Sikes, David; Lecca, Leonid; Gandhi, Neel R; Streicher, Elizabeth M; Dianis, Nancy; Eisenach, Kathleen; Mitnick, Carole D; Horsburgh, C Robert Jr

Contribution of Posttuberculosis Sequelae to Life-Years Lost from Tuberculosis Disease in the United States, 2015-2019

2015-2019年美国结核病后遗症对结核病患者寿命损失的贡献

Menzies, Nicolas A; Marks, Suzanne M; Hsieh, Yuli L; Swartwood, Nicole A; Beeler Asay, Garrett R; Skarbinski, Jacek; Horsburgh, C Robert; Cohen, Ted

Reply to Liao et al.: Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations

回复廖等人:优化低脂肪去脂体重亚洲人群中多重耐药结核病的左氧氟沙星剂量

Phillips, Patrick P J; Peloquin, Charles A; Sterling, Timothy R; Mitnick, Carole D; Horsburgh, C Robert

Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022

2022年扩大针对Medicare人群潜伏性结核感染的靶向检测和治疗的有效性和成本效益

Li, Yunfei; Marks, Suzanne M; Beeler Asay, Garrett R; Winston, Carla A; Pepin, Dawn; McClure, Susan; Swartwood, Nicole A; Cohen, Ted; Horsburgh, C Robert Jr; Salomon, Joshua A; Menzies, Nicolas A